Spectris plc (LSE: SXS) acquired Concept Life Sciences Limited from its management and Equistone Partners Europe for approximately £160 million on January 26, 2018. The consideration is on a debt and cash-free basis and will be financed from existing cash and bank facilities of Spectris plc. Upon completion, Concept Life Sciences Limited will become a separate operating company within Materials Analysis segment of Spectris plc. The current Management team of Concept Life Sciences Limited, led by Michael Fort, will continue to run the business. Tim Morris, Alistair Allen, Julian Hudson, and Chris Whittaker from N M Rothschild & Sons Limited acted as the financial advisors to Equistone Partners Europe, while Addleshaw Goddard acted as legal advisor. Richard Holden, Justin Crowther, Robert Pearce, Tom Cowap and Matt Kumeta of Alantra Corporate Finance acted as financial advisor to Spectris plc. Spectris plc (LSE: SXS) completed the acquisition of Concept Life Sciences Limited from its management and Equistone Partners Europe on January 26, 2018.